Lifestyle Modification-Improving Systemic Athero-Protective Factor, Circulating Pentraxin 3, in High-Risk Patients with Metabolic Syndrome. Cardiology and Cardiovascular Medicine, v. 5, n. 2, p. 201–212, 10 Mar.2021.